HCV polymerase inhibitor pro-drug
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HCV polymerase inhibitor pro-drug, covering 2016-11-02 to 2016-11-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C (CHC) Genotype 1 Infection. [Phase 2]